SARA DOLL: Open Payments
NPI 1679801153 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$928 in 42 payments from 19 companies in 2025. Trend: 2023 $808 · 2024 $727 · 2025 $928
Food & beverage: $768Education: $159
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $157 |
| PFIZER INC. | 5 | $138 |
| SOBI, INC | 2 | $123 |
| Janssen Biotech, Inc. | 5 | $97 |
| Daiichi Sankyo Inc. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $58 |
| Lilly USA, LLC | 2 | $38 |
| Eisai Inc. | 2 | $38 |
| Novartis Pharmaceuticals Corporation | 2 | $34 |
| Celgene Corporation | 1 | $22 |
Products named: ENHERTU, TIVDAK, VENCLEXTA, ELAHERE, RYBREVANT, VERZENIO, Lenvima, REBLOZYL.
Industry payments across ND — which companies pay providers there.
